Claris Lifesciences Ltd.
| BSE: 533288 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE562G01018 |
| BSE 09:19 | 14 Mar | Claris Lifesciences Ltd |
| NSE 05:30 | 01 Jan | Claris Lifesciences Ltd |
| OPEN | 395.10 |
| PREVIOUS CLOSE | 396.05 |
| VOLUME | 1002 |
| 52-Week high | 396.50 |
| 52-Week low | 0.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 2,161 |
| Buy Price | 396.05 |
| Buy Qty | 13.00 |
| Sell Price | 396.90 |
| Sell Qty | 100.00 |
Claris Lifesciences Ltd. (CLARISLIFESCIEN) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 522.55 | 8.75 | 1.70 | 15823.68 |
| Cipla | 950.10 | 34.90 | 3.81 | 13900.58 |
| Dr Reddy's Labs | 4384.35 | -15.55 | -0.35 | 13349.10 |
| Sun Pharma.Inds. | 826.70 | -4.10 | -0.49 | 12803.21 |
| Lupin | 628.55 | 17.15 | 2.81 | 11055.93 |
| Apollo Hospitals | 3735.15 | 55.30 | 1.50 | 9153.00 |
| Zydus Lifesci. | 362.10 | 5.35 | 1.50 | 7790.40 |
| Glenmark Pharma. | 394.00 | 7.00 | 1.81 | 7567.93 |
| Alkem Lab | 3020.25 | 19.20 | 0.64 | 7219.68 |
| Divi's Lab. | 3634.80 | 3.80 | 0.10 | 6798.61 |
| Torrent Pharma. | 2915.00 | 55.60 | 1.94 | 6450.83 |
| Ipca Labs. | 912.90 | 20.95 | 2.35 | 5114.11 |
| Alembic Pharma | 729.35 | -1.60 | -0.22 | 5051.44 |
| Laurus Labs | 466.25 | 1.75 | 0.38 | 4707.04 |
| Abbott India | 19081.95 | 294.60 | 1.57 | 4310.02 |
| Gland Pharma | 2655.90 | -45.95 | -1.70 | 3462.88 |
| Glaxosmi. Pharma | 1503.35 | 3.65 | 0.24 | 3217.51 |
| Granules India | 278.50 | 5.70 | 2.09 | 3134.98 |
| Sanofi India | 6367.75 | -68.65 | -1.07 | 2956.60 |
| Ajanta Pharma | 1264.65 | 29.85 | 2.42 | 2718.59 |
Quick Links for Claris Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
